Comments on: Supplemental New Drug Application For RISPERDAL(R) CONSTA(R) Submitted To The FDA For The Treatment Of Frequently Relapsing Bipolar Disorder

Comments on: Supplemental New Drug Application For RISPERDAL(R) CONSTA(R) Submitted To The FDA For The Treatment Of Frequently Relapsing Bipolar Disorder http://www.druginformations.org/medicine_news/2008/04/17/supplemental-new-drug-application-for-risperdalr-constar-submitted-to-the-fda-for-the-treatment-of-frequently-relapsing-bipolar-disorder/ Your best medicine news resource Sun, 12 Oct 2008 17:08:24 +0000 http://wordpress.org/?v=2.1.2